{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:49:03Z","timestamp":1787932143719,"version":"build-2784847793"},"reference-count":37,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2025.0196","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:52:58Z","timestamp":1765781578000},"source":"Crossref","is-referenced-by-count":3,"title":["Colorectal cancer\u2014diagnosis, treatment, prevention, and long-term follow-up care"],"prefix":"10.3238","author":[{"given":"Matthias Philip","family":"Ebert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Reichermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra Lynen","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"10.3238\/arztebl.m2025.0196_ref1","unstructured":"Robert Koch-Institut: Darmkrebs. Zentrum f\u00fcr Krebsregisterdaten. www.krebsdaten.de\/Krebs\/DE\/Content\/Krebsarten\/Darmkrebs\/darmkrebs_node.html (last accessed on 4 November 2025)."},{"key":"10.3238\/arztebl.m2025.0196_ref2","doi-asserted-by":"crossref","unstructured":"Shiels MS, Haque AT, Berrington de Gonz\u00e1lez A, et al.: Trends in cancer incidence and mortality rates in early-onset and older-onset age groups in the United States, 2010–2019. Cancer Discov 2025; 15: 1363–76.","DOI":"10.1158\/2159-8290.CD-24-1678"},{"key":"10.3238\/arztebl.m2025.0196_ref3","unstructured":"AWMF: Evidenzbericht zur Aktualisierung der S3-Leitlinie „Kolorektales Karzinom“ v3. www.dgvs.de\/wp-content\/uploads\/2023\/04\/LL-KRK_Evidenzbericht_3.0_29.09.25.pdf (last accessed on 13 November 2025)."},{"key":"10.3238\/arztebl.m2025.0196_ref4","unstructured":"AWMF: Langversion der S3-Leitlinie „Kolorektales Karzinom“ v3.0. www.dgvs.de\/wp-content\/uploads\/2023\/04\/LL-KRK_Langversion_3.0_29.09.25.pdf (last accessed on 13 November 2025)."},{"key":"10.3238\/arztebl.m2025.0196_ref5","doi-asserted-by":"crossref","unstructured":"Mandic M, Safizadeh F, Niedermaier T, Hoffmeister M, Brenner H: Association of overweight, obesity, and recent weight loss with colorectal cancer risk. JAMA Netw Open 2023; 6: e239556.","DOI":"10.1001\/jamanetworkopen.2023.9556"},{"key":"10.3238\/arztebl.m2025.0196_ref6","doi-asserted-by":"crossref","unstructured":"Rumgay H, Shield K, Charvat H, et al.: Global burden of cancer in 2020 attributable to alcohol consumption: A population-based study. Lancet Oncol 2021; 22: 1071–80.","DOI":"10.1016\/S1470-2045(21)00279-5"},{"key":"10.3238\/arztebl.m2025.0196_ref7","doi-asserted-by":"crossref","unstructured":"Papadimitriou N, Markozannes G, Kanellopoulou A, et al.: An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites. Nat Commun 2021; 12: 4579.","DOI":"10.1038\/s41467-021-24861-8"},{"key":"10.3238\/arztebl.m2025.0196_ref8","doi-asserted-by":"crossref","unstructured":"Guirguis-Blake J, Evans C, Perdue L, Bean SI, Senger CA: Aspirin use to prevent cardiovascular disease and colorectal cancer: Updated evidence report and systematic review for the US preventive services task force. JAMA 2022; 327: 1585–97.","DOI":"10.1001\/jama.2022.3337"},{"key":"10.3238\/arztebl.m2025.0196_ref9","doi-asserted-by":"crossref","unstructured":"Bretthauer M, L\u00f8berg M, Wieszczy P, et al.: Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med 2022; 387: 1547–56.","DOI":"10.1056\/NEJMoa2208375"},{"key":"10.3238\/arztebl.m2025.0196_ref10","unstructured":"Castells A, Quintero E, Bujanda L, et al.: COLONPREV study investigators. Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): A pragmatic, randomised, controlled, non-inferiority trial. Lancet 2025; 405: 1231–9."},{"key":"10.3238\/arztebl.m2025.0196_ref11","doi-asserted-by":"crossref","unstructured":"Shaukat A, Mongin SJ, Geisser MS, et al.: Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106–14.","DOI":"10.1056\/NEJMoa1300720"},{"key":"10.3238\/arztebl.m2025.0196_ref12","doi-asserted-by":"crossref","unstructured":"Hampel H, Yurgelun M: Point\/counterpoint: Is it time for universal germline genetic testing for all GI cancers?.J Clin Oncol 2022; 40: 2681–692.","DOI":"10.1200\/JCO.21.02764"},{"key":"10.3238\/arztebl.m2025.0196_ref13","unstructured":"TNM Classification of Malignant Tumours, 8th Edition. Wiley 2016."},{"key":"10.3238\/arztebl.m2025.0196_ref14","doi-asserted-by":"crossref","unstructured":"Zessner-Spitzenberg J, Jiricka L, Waldmann E, et al.: Polyp characteristics at screening colonoscopy and post-colonoscopy colorectal cancer mortality: A retrospective cohort study. Gastrointest Endosc 2023; 97: 1109–18.","DOI":"10.1016\/j.gie.2023.01.021"},{"key":"10.3238\/arztebl.m2025.0196_ref15","doi-asserted-by":"crossref","unstructured":"Ferlitsch M, Hassan C, Bisschops R, et al.: Colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—update 2024. Endoscopy 2024; 56: 516–45.","DOI":"10.1055\/a-2304-3219"},{"key":"10.3238\/arztebl.m2025.0196_ref16","doi-asserted-by":"crossref","unstructured":"Zwager L, Bastiaansen B, Montazeri N, et al.: Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: A meta-analysis. Gastroenterology 2022; 163: 174–89.","DOI":"10.1053\/j.gastro.2022.04.010"},{"key":"10.3238\/arztebl.m2025.0196_ref17","doi-asserted-by":"crossref","unstructured":"Luo W, Wu M, Chen Y: Laparoscopic versus open surgery for elderly patients with colorectal cancer: A systematic review and meta-analysis of matched studies. ANZ J Surg 2022; 92: 2003–17.","DOI":"10.1111\/ans.17972"},{"key":"10.3238\/arztebl.m2025.0196_ref18","doi-asserted-by":"crossref","unstructured":"Flynn J, Larach JT, Kong JCH, et al.: Operative and oncological outcomes after robotic rectal resection compared with laparoscopy: A systematic review and meta-analysis. ANZ J Surg 2023; 93: 510–21.","DOI":"10.1111\/ans.18075"},{"key":"10.3238\/arztebl.m2025.0196_ref19","doi-asserted-by":"crossref","unstructured":"Feng Q, Yuan W, Li T, et al.: Robotic vs laparoscopic surgery for middle and low rectal cancer: The REAL Randomized Clinical Trial. JAMA 2025; 334: 136–48.","DOI":"10.1001\/jama.2025.8123"},{"key":"10.3238\/arztebl.m2025.0196_ref20","doi-asserted-by":"crossref","unstructured":"Rahbari NN, Biondo S, Frago R, et al.: Primary tumor resection before systemic therapy in patients with colon cancer and unresectable metastases: Combined results of the SYNCHRONOUS and CCRe-IV trials. J Clin Oncol 2024; 42: 1531–41.","DOI":"10.1200\/JCO.23.01540"},{"key":"10.3238\/arztebl.m2025.0196_ref21","doi-asserted-by":"crossref","unstructured":"Andr\u00e9 T, Meyerhardt J, Iveson T, et al.: Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): Final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol 2020; 21: 1620–9.","DOI":"10.1016\/S1470-2045(20)30527-1"},{"key":"10.3238\/arztebl.m2025.0196_ref22","doi-asserted-by":"crossref","unstructured":"Sinicrope FA, Ou FS, Arnold D, et al.: Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC). J Clin Oncol 2025; 43: LBA1.","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA1"},{"key":"10.3238\/arztebl.m2025.0196_ref23","doi-asserted-by":"crossref","unstructured":"Morton D, Seymour M, Magill L, et al.: Preoperative chemotherapy for operable colon cancer: Mature results of an international randomized controlled trial. J Clin Oncol 2023; 41: 1541–552.","DOI":"10.1200\/JCO.22.00046"},{"key":"10.3238\/arztebl.m2025.0196_ref24","doi-asserted-by":"crossref","unstructured":"Chalabi M, Verschoor YL, Tan PB, et al.: Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer. N Engl J Med 2024; 390: 1949–58.","DOI":"10.1056\/NEJMoa2400634"},{"key":"10.3238\/arztebl.m2025.0196_ref25","doi-asserted-by":"crossref","unstructured":"Diaz LA Jr, Shiu KK, Kim TW, et al.: Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): Final analysis of a randomised, open-label, phase 3 study. Lancet Oncol 2022; 23: 659–70.","DOI":"10.1016\/S1470-2045(22)00197-8"},{"key":"10.3238\/arztebl.m2025.0196_ref26","doi-asserted-by":"crossref","unstructured":"Andre T, Elez E, Van Cutsem E, et al.: Nivolumab plus ipilimumab in microsatellite-instability-high metastatic colorectal cancer. N Engl J Med 2024; 391: 2014–26.","DOI":"10.1056\/NEJMoa2402141"},{"key":"10.3238\/arztebl.m2025.0196_ref27","doi-asserted-by":"crossref","unstructured":"Elez E, Yoshino T, Shen L, et al.: Encorafenib, cetuximab, and mFOLFOX6 BRAF-mutated colorectal cancer. N Engl J Med 2025; 392: 2425–37.","DOI":"10.1056\/NEJMoa2501912"},{"key":"10.3238\/arztebl.m2025.0196_ref28","doi-asserted-by":"crossref","unstructured":"Morris V, Kennedy E, Baxter N, et al.: Treatment of metastatic colorectal cancer: ASCO guideline. J Clin Oncol 2023; 41: 678–700.","DOI":"10.1200\/JCO.22.01690"},{"key":"10.3238\/arztebl.m2025.0196_ref29","doi-asserted-by":"crossref","unstructured":"Cercek A, Lumish M, Sinopoli J, et al.: PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 2022; 386: 2363–76.","DOI":"10.1056\/NEJMoa2201445"},{"key":"10.3238\/arztebl.m2025.0196_ref30","unstructured":"Cercek A, Foote MB, Rousseau B, et al.: Nonoperative management of mismatch repair-deficient tumors. N Engl J Med 2025; 392: 2297–308."},{"key":"10.3238\/arztebl.m2025.0196_ref31","doi-asserted-by":"crossref","unstructured":"Schrag D, Shi Q, Weiser M, et al.: Preoperative treatment of locally advanced rectal cancer. N Engl J Med 2023; 389: 322–34.","DOI":"10.1056\/NEJMoa2303269"},{"key":"10.3238\/arztebl.m2025.0196_ref32","doi-asserted-by":"crossref","unstructured":"Temmink S, Peeters K, Bahadoer R, et al.: Watch and wait after neoadjuvant treatment in rectal cancer: Comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD). Br J Surg 2023; 110: 676–84.","DOI":"10.1093\/bjs\/znad186"},{"key":"10.3238\/arztebl.m2025.0196_ref33","doi-asserted-by":"crossref","unstructured":"Pita-Fern\u00e1ndez S, Alhayek-A\u00ed M, Gonz\u00e1lez-Mart\u00edn C, L\u00f3pez-Calvi\u00f1o B, Seoane-Pillado T, P\u00e9rtega-D\u00edaz S: Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: A systematic review and meta-analysis. Ann Oncol 2015; 26: 644–56.","DOI":"10.1093\/annonc\/mdu543"},{"key":"10.3238\/arztebl.m2025.0196_ref34","doi-asserted-by":"crossref","unstructured":"Jeffery M, Hickey B, Hider P: Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2019; 9: CD002200.","DOI":"10.1002\/14651858.CD002200.pub4"},{"key":"10.3238\/arztebl.m2025.0196_ref35","doi-asserted-by":"crossref","unstructured":"Kennedy E, Zwaal C, Asmis T, et al.: An evidence-based guideline for surveillance of patients after curative treatment for colon and rectal cancer. Curr Oncol 2022; 29: 724–40.","DOI":"10.3390\/curroncol29020062"},{"key":"10.3238\/arztebl.m2025.0196_ref36","unstructured":"Courneya KS, Vardy JL, O‘Callaghan CJ, et al.: Structured exercise after adjuvant chemotherapy for colon cancer. N Engl J Med 2025; 393: 13–25."},{"key":"10.3238\/arztebl.m2025.0196_ref37","doi-asserted-by":"crossref","unstructured":"Scott DA, Mills M, Black A, et al.: Multidimensional rehabilitation programmes for adult cancer survivors. Cochrane Database Syst Rev 2013; 2013: CD007730.","DOI":"10.1002\/14651858.CD007730.pub2"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:53:40Z","timestamp":1765781620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2025.0196","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}